You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

CLINICAL TRIALS PROFILE FOR DIGOXIN PEDIATRIC

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Digoxin Pediatric

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000476 ↗	Digitalis Investigation Group (DIG)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1990-06-01	To determine if digitalis had a beneficial, harmful, or no effect on total mortality in patients with clinical heart failure and sinus rhythm.
NCT00000547 ↗	Enalapril After Anthracycline Cardiotoxicity	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1994-04-01	To determine if the chronic administration of enalapril, an inhibitor of angiotensin converting enzyme (ACE), reduces progression of cardiac dysfunction in pediatric oncology patients who have received anthracyclines, and who are not currently on digoxin, diuretics, or vasodilators for heart failure.
NCT00000556 ↗	Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1995-03-01	To compare two standard treatment strategies for atrial fibrillation: ventricular rate control and anticoagulation vs. rhythm control and anticoagulation.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Digoxin Pediatric

Condition Name

Chart
Table

Condition Name for Digoxin Pediatric
Intervention	Trials
Healthy	36
Atrial Fibrillation	16
Healthy Volunteers	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Digoxin Pediatric
Intervention	Trials
Atrial Fibrillation	24
Heart Failure	22
Breast Neoplasms	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Digoxin Pediatric

Trials by Country

Map
Table

Trials by Country for Digoxin Pediatric
Location	Trials
United States	173
Germany	22
Canada	18
Japan	12
China	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Digoxin Pediatric
Location	Trials
Texas	24
Florida	13
California	12
Ohio	11
New York	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Digoxin Pediatric

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Digoxin Pediatric
Clinical Trial Phase	Trials
Phase 4	25
Phase 3	18
Phase 2/Phase 3	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Digoxin Pediatric
Clinical Trial Phase	Trials
Completed	135
Not yet recruiting	26
Recruiting	24
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Digoxin Pediatric

Sponsor Name

Chart
Table

Sponsor Name for Digoxin Pediatric
Sponsor	Trials
Boehringer Ingelheim	14
Bristol-Myers Squibb	11
AstraZeneca	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Digoxin Pediatric
Sponsor	Trials
Other	173
Industry	146
NIH	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.